Pikumil Pikumil
Arama Sonuçları
Tüm Sonuçları Gör
  • Katıl
    Giriş yapın
    Başvur
    Site içinde arama yapın
    Night Mode

Site içinde arama yapın

Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek

  • Web sayfası bildirimcisi
  • EXPLORE
  • Sayfalar
  • Gruplar
  • Events
  • Reels
  • Blogs
  • Offers
  • Jobs
  • Courses
  • Forums
  • Movies
  • Oyunlar
  • Yazı
  • Blogs
  • Kullanıcılar
  • Sayfalar
  • Gruplar
  • Events
  • Akshay Gorde bir ses eklendi Health
    2026-09-18 14:20:36 -
    Acinetobacter Pneumonia Therapeutics Market Growth is booming worldwide Analysis By Fact.MR
    ROCKVILLE, MARYLAND , Sept 18, 2026 – The Acinetobacter pneumonia therapeutics market is projected to grow from USD 842.6 million in 2026 to USD 1,596.6 million by 2036, recording a compound annual growth rate (CAGR) of 6.6%. The market reached USD 790.4 million in 2025. Absolute opportunity over the forecast period totals USD 754.0 million. The market covers...
    0 Yorumlar 0 hisse senetleri 61 Views 0 önizleme
    Please log in to like, share and comment!
  • Akshay Gorde bir ses eklendi Health
    2026-08-25 13:21:54 -
    Acinetobacter Pneumonia Therapeutics Market Growth, Key Players, SWOT, Revenue Analysis Analysis By Fact.MR
    U.S. Acinetobacter Pneumonia Therapeutics Market Sees Pfizer Driving Innovation as Global Market Expands from USD 842.6 million in 2026 to USD 1,596.6 million by 2036 at a 6.6%. CAGR ROCKVILLE, MARYLAND , August 25, 2026 – The Acinetobacter pneumonia therapeutics market is projected to grow from USD 842.6 million in 2026 to USD 1,596.6 million by 2036, recording a compound...
    0 Yorumlar 0 hisse senetleri 225 Views 0 önizleme
    Please log in to like, share and comment!
  • Priyanka Bhingare bir ses eklendi Other
    2025-12-18 07:53:40 -
    Global Acinetobacter Pneumonia Therapeutics Market Analysis
    The Global Acinetobacter Pneumonia Therapeutics Market Size Was Valued at USD 614.6 Million in 2023 and is Projected to Reach USD 1003.6 Million by 2032, Growing at a CAGR of 5.6% From 2024-2032. Acinetobacter pneumonia therapeutics encompass a specialized range of medical treatments and pharmaceutical interventions designed to combat infections caused by Acinetobacter baumannii, a formidable...
    0 Yorumlar 0 hisse senetleri 802 Views 0 önizleme
    Please log in to like, share and comment!
© 2026 Pikumil Turkish
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek Bengali
About Koşullar Gizlilik Contact Us Rehber